SRF388

Drug identity checked against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Trial of Atezolizumab and Bevacizumab With CHS-388 or Placebo in Patients With Hepatocellular CarcinomaNCT05359861CHRSPhase 2Terminated2025-06-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.